Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VergeRx Feasibility in FQHCs
NCT06161675Active, not recruiting
- Sponsor
- University of Virginia
- Start
- Sep 2024
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University of Virginia. Primary endpoints: Feasibility of Recruitment at 6 months, Feasibility of Randomization at 6 months and 4 more. Started Sep 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06161675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06161675.